Catalyst Wire Dossier Catalyst Wire Dossier

semaglutide B

semaglutide · Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for semaglutide B, covering 2021-01-20 to 2021-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Comparing the Injection Site Pain Experience After the Injection of Semaglutide B and Semaglutide D With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity [Phase 2]

See pricing